Two days a year when we come together, share ideas💡, reconnect 🤝, we remember why we love what we do and why we’re doing it: to make a difference for people living with lung cancer 💙 through collaboration, innovation🚀, and the use of AI 🤖.
This was just day one… and there’s more to come tomorrow! 😀
Thank you all for your collaboration 🎥:
MELISSA FERNANDEZ PINTO Michael Willis Laura Brunelli Anniina Hentinen Layla Giati Vanja Mišković Matteo Sacco Diana Dumitrascu Francesco Trovò Arsela Prelaj Helena Linardou Marina Chiara Garassino Martin Reck Nir Peled Enriqueta Felip
Watch the video here!
🎓 Get ready for the Artificial Intelligence in Cancer Research Summer School co-organized by HeCOG-Hellenic Cooperative Oncology Group, Metropolitan Hospital, ESAC – European Interdisciplinary Society of AI for Cancer Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Ionian University, Technische Universität Dresden
📍 June 13-17, 2025 – Corfu, Greece
Just after the I3LUNG Annual Meeting (that is kicking off tomorrow), the conversation continues with a unique 4-day learning experience where technology meets oncology.
Organized by leading institutions across Europe, this Summer School brings together professionals, researchers and innovators to explore how AI is reshaping cancer research and care.
What’s in store?
🔹 Hands-on workshops
🔹 Expert-led sessions
🔹 Global networking opportunities
Silvia Flor Arnal, Data Holder Manager at the European Federation for Cancer Images (EUCAIM), will share her insights at the upcoming I3LUNG Annual Meeting. But first, she gives us a short preview in this video, introducing EUCAIM and highlighting potential synergies between both European projects.
Watch the video and learn how a pan-European infrastructure is being built to connect clinical and imaging data, driving innovation in cancer research.
Watch the video here!
More news in the upcoming days!
On June 12-13 we will gather in Corfu (Greece) to enjoy two days of collaboration, knowledge and connection. The Annual Meeting brings together the 16 I3LUNG partners from across Europe, the United States and Israel. Together, we will reflect on our progress in the project and align on the way forward.
👀 Want a peek behind the scenes?
We’ll be sharing updates, photos and highlights throughout the event, so stay tuned.
Check out our agenda below 👇🏼
We’re excited to be attending American Society of Clinical Oncology (ASCO) to share latest advances in NSCLC research!
Join us on June 1st at 9:00 AM CDT as Dr. Marina Chiara Garassino from the UChicago Medicine, presents our poster: “Acoustic biomarkers and AI: Transforming NSCLC detection and personalized care”.
📍 Abstract 1568 | Poster board 334
See you in Chicago!
Wow, that was wild. We had great insights in this edition of AI for Oncology, and we wanted to share them with you.
🔬 Key takeaways from this year’s discussions:
🔹 Promising new approaches in multimodal data analysis and the increasing use of multi-agent frameworks.
🔹 Further advances in digital pathology, radiomics, and even single-cell modeling.
🔹 Significant steps ahead towards AI-driven clinical trials.
We’re also proud to highlight the launch of a dedicated scientific page to foster collaboration in AI and oncology: ESAC – European Interdisciplinary Society of AI for Cancer Research make sure to follow and stay tuned!
A special applause to our I3LUNG team and partners for their dedication and contribution to this event 👏
Let’s keep driving AI forward, because the future of cancer care is now, with us!
The event is well underway, bringing together leading experts, researchers, and innovators to explore the latest in AI-driven cancer care.
The I3LUNG team is here on site, and some of our colleagues have already contributed valuable insights as speakers. Swipe through to see some highlights from their sessions!
If you couldn’t attend in person, you can still join us online by clicking here: https://lnkd.in/deSMdAwx
Arsela Prelaj, President of the 3rd edition of the AI for Oncology Congress and Medical Oncologist at the Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, shares why this event is crucial for the future of cancer research and patient care.
With 60 experts from around the world, AI for Oncology will dive deep into the latest advances in AI, from groundbreaking research to real-world clinical implementations. The two-day event will offer a unique opportunity to discover the most relevant and current AI topics in oncology, engage with top scientists, and expand your network.
📅 May 8-9, 2025 | 📍 Milan & Online
💡 Join the conversation! What AI breakthrough are you most excited about?
For more information, visit: www.aiforoncology.it
👉🏼👀 https://www.linkedin.com/feed/update/urn:li:activity:7325072231959523329
The I3LUNG project, led by Principal Investigator Arsela Prelaj, invites you to an unmissable event where global experts will explore how artificial intelligence is revolutionizing oncology. From diagnosis to personalized treatments, discover the latest advancements shaping the future of cancer care. This event will feature I3LUNG project partners and other leading specialists in the field 🚀
📅 When? May 8-9, 2025
📍 Where? Milan – Fondazione IRCCS Istituto Nazionale dei Tumori
💻 Can’t attend in person? No problem! Join us online and be part of the experience.
👉🏼 Information and program: https://lnkd.in/dReRmhz4
👉🏼 Email: segreteria@events-communication.com
From March 26 to 29, the European Lung Cancer Congress brought together international leaders in thoracic oncology, and we are proud to share that Dr. Arsela Prelaj, Principal Investigator of the I3LUNG Project, was one of the featured speakers and also served as chair of the session “The role of AI in lung cancer”, alongside Andreas Rimner.
In this educational session, Arsela presented her talk on the use of Artificial Intelligence in treatment response assessment, a key topic in advancing personalized and more effective medicine for lung cancer patients.
We also want to thank the other speakers of the session: Jakob Nikolas Kather (AI in lung cancer pathology), Florian J. Fintelmann MD (AI in lung cancer imaging), and Joseph (Joe) Deasy (AI in radiation treatment planning) for sharing their knowledge and expertise.